These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma. Massimino M, Gandola L, Spreafico F, Biassoni V, Luksch R, Collini P, Solero CN, Simonetti F, Pignoli E, Cefalo G, Poggi G, Modena P, Mariani L, Potepan P, Podda M, Casanova M, Pecori E, Acerno S, Ferrari A, Terenziani M, Meazza C, Polastri D, Ravagnani F, Fossati-Bellani F. Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1358-63. PubMed ID: 19019566 [Abstract] [Full Text] [Related]
85. [Combined treatment with CDDP and radiation effective against neuroendocrine carcinoma of the urinary bladder: a case report]. Yamaguchi S, Ishizu K, Fujikawa K, Kawamura H, Ohmi C, Konishi M, Naito K, Shimizu Y, Hoshii Y, Takahashi M. Hinyokika Kiyo; 1999 Jul 01; 45(7):489-92. PubMed ID: 10466067 [Abstract] [Full Text] [Related]
93. [A case of malignant neuroepithelioma in the retroperitoneum]. Hara T, Matsuge S, Yamazaki S, Kashiyama M, Izumi H, Mizoe A, Takada M, Hatakeyama H, Takada G, Sugihara T. Gan No Rinsho; 1990 Feb 01; 36(2):199-204. PubMed ID: 2407879 [Abstract] [Full Text] [Related]
96. Paclitaxel/carboplatin versus cyclophosphamide/adriamycin/cisplatin as postoperative adjuvant chemotherapy for advanced endometrial adenocarcinoma. Hidaka T, Nakamura T, Shima T, Yuki H, Saito S. J Obstet Gynaecol Res; 2006 Jun 01; 32(3):330-7. PubMed ID: 16764625 [Abstract] [Full Text] [Related]
97. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma. Schmitz N, Kloess M, Reiser M, Berdel WE, Metzner B, Dorken B, Kneba M, Trumper L, Loeffler M, Pfreundschuh M, Glass B, German High-Grade Non Hodgkin's Lymphoma Study Group (DSHNHL). Cancer; 2006 Jan 01; 106(1):136-45. PubMed ID: 16331635 [Abstract] [Full Text] [Related]